PPAR Gamma Expression Levels during Development of Heart Failure in Patients with Coronary Artery Disease after Coronary Artery Bypass-Grafting

Table 2

Baseline patients characteristics.

Parameters
Mean age, yrs (±SD)	63.8 (±8.81)
Sex/men, (%)	133 (85%)
BMI, kg/m^2 (±SD)	27.1 (±3.10)
Prior MI, (%)	56 (36%)
Anterior wall	13 (8%)
Inferior wall	32 (21%)
Posterior wall	8 (5%)
Lateral wall	6 (4%)
Hypertension, (%)	98 (62%)
Hypercholesterolaemia, (%)	157 (100%)
Killip class, (%)
I	157 (100%)
HR, min^−1 (±SD)	68.7 (±7.64)
BPsys, mmHg (±SD)	131.8 (±12.20)
BPdias, mmHg (±SD)	79.1 (±5.15)
Creatinine, umol/L (±SD)	89.0 (±31.9)
MDRD, mL/min/1.73 m^2 (±SD)	74.2 (±14.7)
Hemoglobin, g/dL (±SD)	13.56 (±1.98)
Hematocrit, % (±SD)	39.4 (±6.90)
NT-pro BNP, ng/m (±SD)	195.0 (±101.98)
6MWT, m (±SD)	443.0 (±58.51)
EF < 40%, (%)	0
LV > 5.6 cm, (%)	0
ASA, (%)	155 (99%)
B-blockers, (%)	154 (99%)
ACE-I, (%)	144 (92%)
ARB, (%)	4 (3%)
Diuretics, (%)	20 (13%)
Inhibitors of aldosterone, (%)	10 (6%)
Statins, (%)	153 (98%)